BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19456279)

  • 1. Selective MMP-12 inhibitors: WO-2008057254.
    Norman P
    Expert Opin Ther Pat; 2009 Jul; 19(7):1029-34. PubMed ID: 19456279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective matrix metalloprotease 12 inhibitor for potential treatment of chronic obstructive pulmonary disease (COPD): discovery of (S)-2-(8-(methoxycarbonylamino)dibenzo[b,d]furan-3-sulfonamido)-3-methylbutanoic acid (MMP408).
    Li W; Li J; Wu Y; Wu J; Hotchandani R; Cunningham K; McFadyen I; Bard J; Morgan P; Schlerman F; Xu X; Tam S; Goldman SJ; Williams C; Sypek J; Mansour TS
    J Med Chem; 2009 Apr; 52(7):1799-802. PubMed ID: 19278250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of potent and selective matrix metalloprotease 12 inhibitors for the potential treatment of chronic obstructive pulmonary disease (COPD).
    Wu Y; Li J; Wu J; Morgan P; Xu X; Rancati F; Vallese S; Raveglia L; Hotchandani R; Fuller N; Bard J; Cunningham K; Fish S; Krykbaev R; Tam S; Goldman SJ; Williams C; Mansour TS; Saiah E; Sypek J; Li W
    Bioorg Med Chem Lett; 2012 Jan; 22(1):138-43. PubMed ID: 22153340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
    Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
    Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
    J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and SAR of highly selective MMP-13 inhibitors.
    Li J; Rush TS; Li W; DeVincentis D; Du X; Hu Y; Thomason JR; Xiang JS; Skotnicki JS; Tam S; Cunningham KM; Chockalingam PS; Morris EA; Levin JI
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4961-6. PubMed ID: 16153831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metalloprotease inhibitors as anti-inflammatory agents: an evolving target?
    Whelan CJ
    Curr Opin Investig Drugs; 2004 May; 5(5):511-6. PubMed ID: 15202724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alkyl diphenylacetyl, 9H-xanthene- and 9H-thioxanthene-carbonyl carbamates as positive allosteric modulators of mGlu1 receptors.
    Wichmann J; Bleicher K; Vieira E; Woltering T; Knoflach F; Mutel V
    Farmaco; 2002 Dec; 57(12):989-92. PubMed ID: 12564473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Which of three structures is AZD-3199? WO-2008104790, WO-2008096112 and WO-2008096119.
    Norman P
    Expert Opin Ther Pat; 2009 Aug; 19(8):1157-63. PubMed ID: 19563269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage metalloelastase (MMP-12) as a target for inflammatory respiratory diseases.
    Lagente V; Le Quement C; Boichot E
    Expert Opin Ther Targets; 2009 Mar; 13(3):287-95. PubMed ID: 19236151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new class of potent matrix metalloproteinase 13 inhibitors for potential treatment of osteoarthritis: Evidence of histologic and clinical efficacy without musculoskeletal toxicity in rat models.
    Baragi VM; Becher G; Bendele AM; Biesinger R; Bluhm H; Boer J; Deng H; Dodd R; Essers M; Feuerstein T; Gallagher BM; Gege C; Hochgürtel M; Hofmann M; Jaworski A; Jin L; Kiely A; Korniski B; Kroth H; Nix D; Nolte B; Piecha D; Powers TS; Richter F; Schneider M; Steeneck C; Sucholeiki I; Taveras A; Timmermann A; Van Veldhuizen J; Weik J; Wu X; Xia B
    Arthritis Rheum; 2009 Jul; 60(7):2008-18. PubMed ID: 19565489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
    Li W; Li J; Wu Y; Rancati F; Vallese S; Raveglia L; Wu J; Hotchandani R; Fuller N; Cunningham K; Morgan P; Fish S; Krykbaev R; Xu X; Tam S; Goldman SJ; Abraham W; Williams C; Sypek J; Mansour TS
    J Med Chem; 2009 Sep; 52(17):5408-19. PubMed ID: 19725580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2,3-Dihydro-1,3-dioxo-1H-isoindole-5-carboxylic acid derivatives: a novel class of small molecule heparanase inhibitors.
    Courtney SM; Hay PA; Buck RT; Colville CS; Porter DW; Scopes DI; Pollard FC; Page MJ; Bennett JM; Hircock ML; McKenzie EA; Stubberfield CR; Turner PR
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3269-73. PubMed ID: 15149688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies.
    Bora-Tatar G; Dayangaç-Erden D; Demir AS; Dalkara S; Yelekçi K; Erdem-Yurter H
    Bioorg Med Chem; 2009 Jul; 17(14):5219-28. PubMed ID: 19520580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting matrix metalloproteinase 12: its role in pathophysiology of asthma and related pulmonary diseases.
    Abd-Elaziz K; Jesenak M; Vasakova M; Diamant Z
    Curr Opin Pulm Med; 2021 Jan; 27(1):54-60. PubMed ID: 33065600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cilomilast GlaxoSmithKline.
    Brown WM
    Curr Opin Investig Drugs; 2005 May; 6(5):545-58. PubMed ID: 15912970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of cytochrome p450 and matrix metalloproteinase in chronic obstructive pulmonary disease.
    Cheng SL; Yu CJ; Yang PC
    Biochem Genet; 2009 Aug; 47(7-8):591-601. PubMed ID: 19507017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
    Tessier P; Smil DV; Wahhab A; Leit S; Rahil J; Li Z; Déziel R; Besterman JM
    Bioorg Med Chem Lett; 2009 Oct; 19(19):5684-8. PubMed ID: 19699639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease].
    Shteinberg M; Weiler-Ravel D; Adir Y
    Harefuah; 2009 May; 148(5):333-6, 348. PubMed ID: 19630366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E; Lazarus SC
    J Allergy Clin Immunol; 2009 Nov; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.